Can human xylosyltransferase-1 serve as a biomarker and therapeutic target for corneal fibrosis?

dc.contributor.author	Smith, Kaitlin E.	eng
dc.contributor.author	Tripathi, Ratnakar	eng
dc.contributor.author	Gupta, Suneel	eng
dc.contributor.author	Anumanthan, Govindaraj	eng
dc.contributor.author	Hesemann, Nathan P.	eng
dc.contributor.author	Mohan, Rajiv R.	eng
dc.contributor.meetingname	Health Sciences Research Day (2016 : University of Missouri)	eng
dc.date.issued	2016	eng
dc.description.abstract	Tested was the hypothesis that XYLT1 plays an important role in corneal wound healing and scarring and may allow development of newer strategies for curing corneal fibrosis. The specific aims were: 1) to characterize XYLT1 expression in normal and wounded human and rabbit corneas, 2) investigate its role in corneal wound healing, and 2) determine whether XYLT1 can serve as a biomarker for corneal fibrosis.	eng
dc.format.extent	1 poster	eng
dc.identifier.uri	https://hdl.handle.net/10355/55718
dc.language	English	eng
dc.relation.ispartofcommunity	University of Missouri--Columbia. Health Sciences Research Day	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject	corneal wound healing, corneal scarring, immunohistochemistry	eng
dc.title	Can human xylosyltransferase-1 serve as a biomarker and therapeutic target for corneal fibrosis?	eng
dc.type	Poster	eng